The polycomb group protein BMI-1 inhibitor PTC-209 is a potent anti-myeloma agent alone or in combination with epigenetic inhibitors targeting EZH2 and the BET bromodomains.
about
The polycomb group protein BMI-1 inhibitor PTC-209 is a potent anti-myeloma agent alone or in combination with epigenetic inhibitors targeting EZH2 and the BET bromodomains.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
The polycomb group protein BMI ...... EZH2 and the BET bromodomains.
@en
The polycomb group protein BMI ...... EZH2 and the BET bromodomains.
@nl
type
label
The polycomb group protein BMI ...... EZH2 and the BET bromodomains.
@en
The polycomb group protein BMI ...... EZH2 and the BET bromodomains.
@nl
prefLabel
The polycomb group protein BMI ...... EZH2 and the BET bromodomains.
@en
The polycomb group protein BMI ...... EZH2 and the BET bromodomains.
@nl
P2093
P2860
P50
P356
P1433
P1476
The polycomb group protein BMI ...... EZH2 and the BET bromodomains.
@en
P2093
Alba Atienza Párraga
Anders Österborg
Antonia Kalushkova
Caroline A Heckman
Fredrik Öberg
Helena Jernberg-Wiklund
Kenneth Nilsson
P2860
P304
103731-103743
P356
10.18632/ONCOTARGET.21909
P407
P577
2017-10-20T00:00:00Z